We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Supplemental Zinc Helps Fight Infant Infections

By HospiMedica International staff writers
Posted on 12 Jul 2012
Adding oral zinc to standard antibiotics reduced the risk of treatment failure by 40% compared with standard antibiotics alone in the treatment for serious infection in infants in developing countries, according to a new study.

Researchers at the Translational Health Science and Technology Institute (THSTI; Gurgaon, India), the University of Bergen (Norway), and other institutions conducted a randomized double-blind, placebo-controlled trial, that enrolled infants aged 7-120 days with probable serious bacterial infection at three hospitals in New Delhi (India), between July 6, 2005, and Dec 3, 2008. More...
In all, 352 infants were assigned to receive 10 mg of zinc and 348 were assigned to receive placebo orally every day, in addition to standard antibiotic treatment. The primary outcome measure was treatment failure--defined as a need to change antibiotics within 7 days of randomization--or a need for intensive care, or death at any time within 21 days.

The results showed that significantly fewer treatment failures occurred in the zinc group (10%) than in the placebo group (17%), implying that treatment of 15 infants with zinc would prevent one treatment failure. In all, ten infants receiving zinc died, compared with 17 given placebo. Among the components, need for intensive care occurred in one zinc-treated infant and two in the placebo group. Change of antibiotics occurred equally often between groups for worsening of initial clinical features, but less often in the zinc group for persistence of initial clinical features. Recovery time did not improve with zinc. The study was published early online on May 21, 2012, in the Lancet.

“Infants with diarrhea appeared to particularly benefit, with a relative risk reduction of 69% compared with placebo. That benefit may have stemmed from replenishing zinc stores depleted by loss in stool,” concluded lead author Shinjini Bhatnagar, PhD, of the THSTI, and colleagues. “Zinc is important for mucosal barrier function and components of innate and adaptive immunity, such as lytic activity of phagocytes and natural killer cells, and expression of cytokines.”

Zinc is an essential trace element, necessary for plants, animals, and microorganisms. Zinc is found in nearly 100 specific enzymes, serves as structural ions in transcription factors, and is stored and transferred in metallothioneins. There are 2-4 grams of zinc distributed throughout the human body. Most zinc is in the brain, muscle, bones, kidney, and liver, with the highest concentrations in the prostate and parts of the eye. In humans, zinc interacts with a wide range of organic ligands, and has roles in the metabolism of RNA and DNA, signal transduction, and gene expression.

Related Links:

Translational Health Science and Technology Institute
University of Bergen




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Tourniquet System
heidi– mein Tourniquet
New
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.